Park Street Nordicom A/S
Transactions during 27 January 2021 – 03 February 2021
On 19 October 2020, Park Street Nordicom A/S announced a share buy-back programme, as described in Company Announcement No. 8/2020. The programme is carried out in compliance with the provisions of Regulation No 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation – MAR) and delegated legislation under MAR; except for the limitation of implementing the authorized buy-back of the Company’s shares within the 25% daily trading volume, due to the low levels of market liquidity in the Company’s shares. According to the programme, Park Street Nordicom A/S will repurchase A shares of up to DKK 11.9m. The programme is taking place during the period from 19 October 2020 to 25 February 2021.
The following transactions were made under the share buy-back programme during 27 January 2021 - 03 February 2021:
Number of shares bought | Average transaction price | Number of transactions | |
Accumulated, last announcement | 918,313 | 192 | |
27 January 2021 | - | - | - |
28 January 2021 | - | - | - |
29 January 2021 | - | - | - |
01 February 2021 | - | - | - |
02 February 2021 | - | - | - |
03 February 2021 | - | - | - |
Total, 27 January 2021 - 03 February 2021 | - | - | - |
Accumulated under the programme | 918,313 | 192 |
Details of transactions executed under the buyback program are enclosed.
Enquiries regarding this announcement should be addressed to:
David Casado, Head of Finance at nordicom@nordicom.dk
Company Website: www.psnas.com
Telephone Number: +45 33 33 93 03
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
Zealand Pharma17.10.2025 17:05:17 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom